Santillana, Edgardo A.
HRN: 28-90-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
CEFTRIAXONE 1G (VIAL)
04/29/2026
05/05/2026
IV
2G
OD
Obstructive Jaundice Sec To Malignant Pancreatic Head Mass
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: